Cargando…
Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis
BACKGROUND: Identification of clinical phenotypes in critically ill COVID-19 patients could improve understanding of the disease heterogeneity and enable prognostic and predictive enrichment. However, previous attempts did not take into account temporal dynamics with high granularity. By including t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902809/ https://www.ncbi.nlm.nih.gov/pubmed/36744415 http://dx.doi.org/10.1177/08850666231153393 |
_version_ | 1784883341928955904 |
---|---|
author | Siepel, Sander Dam, Tariq A. Fleuren, Lucas M. Girbes, Armand R.J. Hoogendoorn, Mark Thoral, Patrick J. Elbers, Paul W.G. Bennis, Frank C. |
author_facet | Siepel, Sander Dam, Tariq A. Fleuren, Lucas M. Girbes, Armand R.J. Hoogendoorn, Mark Thoral, Patrick J. Elbers, Paul W.G. Bennis, Frank C. |
author_sort | Siepel, Sander |
collection | PubMed |
description | BACKGROUND: Identification of clinical phenotypes in critically ill COVID-19 patients could improve understanding of the disease heterogeneity and enable prognostic and predictive enrichment. However, previous attempts did not take into account temporal dynamics with high granularity. By including the dimension of time, we aim to gain further insights into the heterogeneity of COVID-19. METHODS: We used granular data from 3202 adult COVID patients in the Dutch Data Warehouse that were admitted to one of 25 Dutch ICUs between February 2020 and March 2021. Parameters including demographics, clinical observations, medications, laboratory values, vital signs, and data from life support devices were selected. Twenty-one datasets were created that each covered 24 h of ICU data for each day of ICU treatment. Clinical phenotypes in each dataset were identified by performing cluster analyses. Both evolution of the clinical phenotypes over time and patient allocation to these clusters over time were tracked. RESULTS: The final patient cohort consisted of 2438 COVID-19 patients with a ICU mortality outcome. Forty-one parameters were chosen for cluster analysis. On admission, both a mild and a severe clinical phenotype were found. After day 4, the severe phenotype split into an intermediate and a severe phenotype for 11 consecutive days. Heterogeneity between phenotypes appears to be driven by inflammation and dead space ventilation. During the 21-day period, only 8.2% and 4.6% of patients in the initial mild and severe clusters remained assigned to the same phenotype respectively. The clinical phenotype half-life was between 5 and 6 days for the mild and severe phenotypes, and about 3 days for the medium severe phenotype. CONCLUSIONS: Patients typically do not remain in the same cluster throughout intensive care treatment. This may have important implications for prognostic or predictive enrichment. Prominent dissimilarities between clinical phenotypes are predominantly driven by inflammation and dead space ventilation. |
format | Online Article Text |
id | pubmed-9902809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-99028092023-02-07 Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis Siepel, Sander Dam, Tariq A. Fleuren, Lucas M. Girbes, Armand R.J. Hoogendoorn, Mark Thoral, Patrick J. Elbers, Paul W.G. Bennis, Frank C. J Intensive Care Med Original Research BACKGROUND: Identification of clinical phenotypes in critically ill COVID-19 patients could improve understanding of the disease heterogeneity and enable prognostic and predictive enrichment. However, previous attempts did not take into account temporal dynamics with high granularity. By including the dimension of time, we aim to gain further insights into the heterogeneity of COVID-19. METHODS: We used granular data from 3202 adult COVID patients in the Dutch Data Warehouse that were admitted to one of 25 Dutch ICUs between February 2020 and March 2021. Parameters including demographics, clinical observations, medications, laboratory values, vital signs, and data from life support devices were selected. Twenty-one datasets were created that each covered 24 h of ICU data for each day of ICU treatment. Clinical phenotypes in each dataset were identified by performing cluster analyses. Both evolution of the clinical phenotypes over time and patient allocation to these clusters over time were tracked. RESULTS: The final patient cohort consisted of 2438 COVID-19 patients with a ICU mortality outcome. Forty-one parameters were chosen for cluster analysis. On admission, both a mild and a severe clinical phenotype were found. After day 4, the severe phenotype split into an intermediate and a severe phenotype for 11 consecutive days. Heterogeneity between phenotypes appears to be driven by inflammation and dead space ventilation. During the 21-day period, only 8.2% and 4.6% of patients in the initial mild and severe clusters remained assigned to the same phenotype respectively. The clinical phenotype half-life was between 5 and 6 days for the mild and severe phenotypes, and about 3 days for the medium severe phenotype. CONCLUSIONS: Patients typically do not remain in the same cluster throughout intensive care treatment. This may have important implications for prognostic or predictive enrichment. Prominent dissimilarities between clinical phenotypes are predominantly driven by inflammation and dead space ventilation. SAGE Publications 2023-02-06 2023-07 /pmc/articles/PMC9902809/ /pubmed/36744415 http://dx.doi.org/10.1177/08850666231153393 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Siepel, Sander Dam, Tariq A. Fleuren, Lucas M. Girbes, Armand R.J. Hoogendoorn, Mark Thoral, Patrick J. Elbers, Paul W.G. Bennis, Frank C. Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis |
title | Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis |
title_full | Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis |
title_fullStr | Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis |
title_full_unstemmed | Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis |
title_short | Evolution of Clinical Phenotypes of COVID-19 Patients During Intensive Care Treatment: An Unsupervised Machine Learning Analysis |
title_sort | evolution of clinical phenotypes of covid-19 patients during intensive care treatment: an unsupervised machine learning analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902809/ https://www.ncbi.nlm.nih.gov/pubmed/36744415 http://dx.doi.org/10.1177/08850666231153393 |
work_keys_str_mv | AT siepelsander evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT damtariqa evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT fleurenlucasm evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT girbesarmandrj evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT hoogendoornmark evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT thoralpatrickj evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT elberspaulwg evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT bennisfrankc evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis AT evolutionofclinicalphenotypesofcovid19patientsduringintensivecaretreatmentanunsupervisedmachinelearninganalysis |